Facebook Linkedin Twitter
Inside Precision Medicine Generative AI Used to Develop T Cell Cancer Immunotherapy

Cell immunotherapy

Translucent robotic looking hand holding a test tube next to a screen showing code and a digital pill to symbolize the use of AI to develop new protein phase separation drugs
News & Features

Generative AI Used to Develop T Cell Cancer Immunotherapy

Helen Albert -
0
CAR T-Cell Immunotherapy
News & Features

Adding Mutated Gene Could Boost CAR T as Treatment for Solid Tumors

Chris Anderson -
0
Immature blood cells in leukemia.
News & Features

Biomarkers of CAR T-Cell Response in Pediatric Leukemia Found

Malorye Branca -
0
CAR T-Cell Immunotherapy
News & Features

Vaccine Boost to CAR T Therapy May Help Address Solid Tumors

Chris Anderson -
0
CAR T cell immunotherapy, illustration
News & Features

CAR-T Adaptation Could Treat Myasthenia Gravis

Chris Anderson -
0
CAR T cell immunotherapy, illustration
News & Features

Autolus Confirms Positive Phase II Findings for Obe-cel CAR T-Cell Therapy

Helen Albert -
0
Umoja Biopharma lab
News & Features

Confronting Challenges in Developing Cell and Gene Therapies

Kathy Vuksanaj -
0
Neuroblastoma cells microscope image
News & Features

CAR-NKT Therapy against Neuroblastoma Shows Promising Results in Clinical Trial

Alisa Kirkin -
0
CAR T cell immunotherapy, illustration
News & Features

New Technology Could Enable Personalized T Cell-Based Immunotherapies

Alisa Kirkin -
0
Illustration of human kidneys in blue, surrounded by red cancer cells to illustrate renal cell carcinoma before treatment with allogeneic CAR T-cell therapy.
News & Features

Allogene’s “Off-the-Shelf” CAR T-Cell Therapy Shows Early Promise

Helen Albert -
0
12345Page 3 of 5

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine